Fig. 1

Kaplan-Meier survival curve analysis for all-cause death (a), cardiac death (b), and major adverse cardiovascular events (MACE) according to low (< 420 ng/mL), median (420–1150 ng/mL), and high (≥ 1150 ng/mL) levels of D-dimer